Rocket Lab USA, Inc.
Rocket Lab USA, Inc. (RKLB) Financial Performance & Income Statement Overview
Review Rocket Lab USA, Inc. (RKLB) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Rocket Lab USA, Inc. (RKLB) Income Statement & Financial Overview
Review Rocket Lab USA, Inc. RKLB income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $122.57M | $132.39M | $104.81M | $106.25M |
| Cost of Revenue | $87.32M | $95.57M | $76.81M | $82.04M |
| Gross Profit | $35.25M | $36.82M | $28.00M | $24.21M |
| Gross Profit Ratio | $0.29 | $0.28 | $0.27 | $0.23 |
| R&D Expenses | $55.11M | $48.26M | $47.72M | $38.86M |
| SG&A Expenses | $39.33M | $40.11M | $32.17M | $30.52M |
| Operating Expenses | $94.44M | $88.37M | $79.89M | $70.44M |
| Total Costs & Expenses | $181.76M | $183.94M | $156.71M | $149.53M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.59M | $1.78M | $454000.00 | $824000.00 |
| Depreciation & Amortization | $8.71M | $9.14M | $8.10M | $7.64M |
| EBITDA | -$50.14M | -$40.75M | -$42.45M | -$34.02M |
| EBITDA Ratio | -$0.41 | -$0.31 | -$0.40 | -$0.32 |
| Operating Income | -$59.19M | -$51.55M | -$51.90M | -$43.27M |
| Operating Income Ratio | -$0.48 | -$0.39 | -$0.50 | -$0.41 |
| Other Income/Expenses (Net) | -$2.24M | -$121000.00 | $904000.00 | $783000.00 |
| Income Before Tax | -$61.43M | -$51.67M | -$50.99M | -$42.49M |
| Income Before Tax Ratio | -$0.50 | -$0.39 | -$0.49 | -$0.40 |
| Income Tax Expense | -$813000.00 | $675000.00 | $944000.00 | -$860000.00 |
| Net Income | -$60.62M | -$52.34M | -$51.94M | -$41.63M |
| Net Income Ratio | -$0.49 | -$0.40 | -$0.50 | -$0.39 |
| EPS | -$0.12 | -$0.10 | -$0.10 | -$0.08 |
| Diluted EPS | -$0.12 | -$0.10 | -$0.10 | -$0.08 |
| Weighted Avg Shares Outstanding | $505.61M | $501.75M | $497.70M | $494.19M |
| Weighted Avg Shares Outstanding (Diluted) | $505.61M | $501.75M | $497.70M | $494.19M |
The company's financials show resilient growth, with revenue advancing from $106.25M in Q2 2024 to $122.57M in Q1 2025. Gross profit remained healthy with margins at 29% in Q1 2025 compared to 23% in Q2 2024. Operating income hit -$59.19M last quarter, sustaining a consistent -48% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$50.14M. Net income dropped to -$60.62M, while earnings per share reached -$0.12. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan